Stewart W. Schneller

Auburn University At Auburn

$5,831,975

Attributed

$5,831,975

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2005–07

$2M$1.5M$1M$500K$0

'05

'06

'07

Funding mix

By agency

NIH$7,937,948 · 3

By mechanism

U19$5,503,457 · 1

U01$2,434,491 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Drug Design /Synthesis /Production”

Dennis L. Kasper · Harvard Medical School$26,605,444
Myron Max Levine · University Of Maryland Baltimore$22,074,862
George R Painter · Chimerix, Inc.$19,230,662
Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
Dennis E. Hruby · Oregon State University$9,654,233
William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679

Research focus

Drug Design /Synthesis /ProductionAntiviral AgentsPoxviridaeCooperative StudyNucleoside AnalogHydrolaseMethyltransferaseDrug Screening /EvaluationBioterrorism /Chemical WarfareEnzyme InhibitorsAdenosineHomocysteineVirus DiseasesMononegaviralesSmallpox VirusMicroorganism Disease ChemotherapyCowpox VirusBiologicalCommunicable DiseasesCollaborationsBelgiumAlabamaGeorgia, UsaFilovirus